Literature DB >> 1378759

The mitochondrial tRNA(Leu)(UUR)) mutation in MELAS: a model for pathogenesis.

E A Schon1, Y Koga, M Davidson, C T Moraes, M P King.   

Abstract

The A----G transition at nucleotide 3243 of the mitochondrial tRNA(Leu)(UUR)) gene has been associated with MELAS, a maternally-inherited mitochondrial disorder. We recently transferred mitochondria harboring this mtDNA mutation into a human cell line devoid of endogenous mtDNA (rho degrees cells), and showed: (1) decreased rate of synthesis and of steady-state levels of mitochondrial translational products, (2) reduced respiratory chain function and (3) increased amounts of a novel unprocessed RNA species (termed by us RNA 19) derived from transcription of the 16S rRNA + tRNA(Leu)(UUR) + ND 1 genes. Because RNA 19 contains rRNA sequences, we propose that this molecule is incorporated into mitochondrial ribosomes, and interferes disproportionately with mitochondrial translation, thereby causing the phenotypic changes associated with MELAS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378759

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  The RNase P associated with HeLa cell mitochondria contains an essential RNA component identical in sequence to that of the nuclear RNase P.

Authors:  R S Puranam; G Attardi
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 2.  Disease-related versus polymorphic mutations in human mitochondrial tRNAs. Where is the difference?

Authors:  C Florentz; M Sissler
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

3.  Structural probing of a pathogenic tRNA dimer.

Authors:  Marc D Roy; Lisa M Wittenhagen; Shana O Kelley
Journal:  RNA       Date:  2005-03       Impact factor: 4.942

4.  Comparative analysis of the pathogenic mechanisms associated with the G8363A and A8296G mutations in the mitochondrial tRNA(Lys) gene.

Authors:  Belén Bornstein; José Antonio Mas; Clarice Patrono; Miguel Angel Fernández-Moreno; Emiliano González-Vioque; Yolanda Campos; Rosalba Carrozzo; Miguel Angel Martín; Pilar del Hoyo; Filippo M Santorelli; Joaquín Arenas; Rafael Garesse
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

5.  Fine mapping of mitochondrial RNAs derived from the mtDNA region containing a point mutation associated with MELAS.

Authors:  Y Koga; M Davidson; E A Schon; M P King
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

Review 6.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 7.  Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseases.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot?

Authors:  C T Moraes; F Ciacci; E Bonilla; C Jansen; M Hirano; N Rao; R E Lovelace; L P Rowland; E A Schon; S DiMauro
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene.

Authors:  F Merante; I Tein; L Benson; B H Robinson
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

10.  Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease.

Authors:  Juan Garrido-Maraver; Mario D Cordero; Irene Domínguez Moñino; Sheila Pereira-Arenas; Ana V Lechuga-Vieco; David Cotán; Mario De la Mata; Manuel Oropesa-Ávila; Manuel De Miguel; Juan Bautista Lorite; Eloy Rivas Infante; Manuel Alvarez-Dolado; Plácido Navas; Sandra Jackson; Silvia Francisci; José A Sánchez-Alcázar
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.